Vasculopathy in the kidney allograft at time of transplantation: Impact on later function of the graft

Transplantation

Volumn 85, Issue 7 SUPPL., 2008, Pages

  Woestenburg, Annemie ^a   Sennesael, Jacques ^a   Bosmans, Jean Louis ^b   Verbeelen, Dierik ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Biopsy; Hyalinosis; Intimal thickening; Kidney function

Indexed keywords

ARTERIOSCLEROSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; CORRELATION ANALYSIS; DELAYED GRAFT FUNCTION; DISEASE SEVERITY; FIBROMUSCULAR DYSPLASIA; FOLLOW UP; GRAFT FAILURE; GRAFT SURVIVAL; HISTOPATHOLOGY; HOSPITAL DISCHARGE; HUMAN; KIDNEY ALLOGRAFT; KIDNEY DONOR; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; POSTOPERATIVE PERIOD; PREDICTOR VARIABLE; PRIORITY JOURNAL; SCORING SYSTEM; SURVIVAL RATE; SURVIVAL TIME; VASCULAR DISEASE;

BIOPSY; DELAYED GRAFT FUNCTION; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; VASCULAR DISEASES;

EID: 42049100183     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318169c311     Document Type: Article

References (54)

1. Laupacis A, Keown P, Pus N, et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int 1996; 50: 235.
2. Edwards EB, Bennett LE, Cecka JM. Effect of HLA mismatching on the relative risk of mortality for kidney recipients: A comparison of the mortality risk after transplant to the mortality risk of remaining on the waiting list. Transplantation 1997; 64: 1274.
3. Sanchez-Fructuoso AI, Prats D, Torrente J, et al. Renal transplantation from non-heart-beating donors: A promising alternative to enlarge the donor pool. J Am Soc Nephrol 2000; 11: 350.
4. Kasiske L. Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int 1987; 31: 1153.
5. Curschellas E, Landmann J, Dürig M, et al. Morphologic findings in "zero-hour" biopsies of renal transplants. Clin Nephrol 1991; 36: 215.
6. Minakawa R, Tyden G, Lindholm B, et al. Donor kidney vasculopathy: Impact on outcome in kidney transplantation. Transpl Immunol 1996; 4: 309.
7. Pokorna E, Vitko S, Chadimova M, et al. Adverse effect of donor arteriolosclerosis on graft outcome after renal transplantation. Nephrol Dial Transplant 2000; 15: 705.
8. Ortiz F, Paavonen T, Tornroth T, et al. Predictors of renal allograft histologic damage progression. J Am Soc Nephrol 2005; 16: 817.
9. Verran D, deLeon C, Chui A, et al. Factors in older cadaveric organ donors impacting on renal allograft outcome. Clin Transplant 2001; 15: 1.
10. Ojo A, Leichtman A, Punch J, et al. Impact of pre-existing donor hypertension and diabetes mellitus on cadaveric renal transplant outcomes. Am J Kidney Dis 2000; 36: 153.
11. Perico N, Ruggenenti P, Scalamogna M, et al. Tackling the shortage of donor kidneys:Howto use the best that we have. Am J Nephrol 2003; 23: 245.
12. Agati VD, Cohen D. Preimplantation renal biopsy: Structure does predict function. Transplantation 2003; 75: 264.
13. Nyberg S, Matas A, Rogers M, et al. Donor scoring system for cadaveric renal transplantation. Am J Transplant 2001; 1: 162.
14. Seron D, Arias M, Campistol J, et al. Late renal allograft failure between 1990 and 1998 in Spain: A changing scenario. Transplantation 2003; 76: 1588.
15. Bia MJ. Nonimmunologic causes of late renal graft loss. Kidney Int 1995; 47: 1470.
16. Paul LC. Chronic allograft nephropathy: An update. Kidney Int 1999; 56: 783.
17. Racusen L, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713.
18. Isoniemi H, Taskinen E, Hävry P. Histological chronic allograft damage index accurately predicts chronic renal allograft rejection. Transplantation 1994; 58: 1195.
19. Cosyns JP, Malaise J, Hanique G, et al. Lesions in donor kidneys: Nature, incidence and influence on graft function. Transpl Int 1998; 11: 22.
20. Lopes J, Moreso F, Riera L, et al. Evaluation of pre-implantation kidney biopsies: Comparison of Banff criteria to a morphometric approach. Kidney Int 2005; 67: 1595.
21. Di Paolo S, Stallone G, Schena A, et al. Hypertension is an independent predictor of delayed graft function and worse renal function only in kidneys with chronic pathological lesions. Transplantation 2002; 73: 623.
22. Remuzzi G, Grinyo J, Ruggenti P, et al. Early experience with dual kidney transplantation in adults using expanded donor criteria. J Am Soc Nephrol 1999; 10: 2591.
23. Mihatsch J, Antonovych T, Bohman SO, et al. Cyclosporin A nephropathy: Standardization of the evaluation of kidney biopsies. Clin Nephrol 1994; 41: 23.
24. Marcussen N, Olsen TS, Benediktsson H, et al. Reproducibility of the Banff classification of renal allograft pathology. Transplantation 1995; 60: 1083.
25. Furness PN, Taub N. International variation in the interpretation of renal transplant biopsies: Report of the CERTPAP project. Kidney Int 2001; 60: 1998.
26. Moreso F, Lopez M, Vallejos A, et al. Serial protocol biopsies to quantify the progression of chronic transplant nephropathy in stable renal allografts. Am J Transplant 2001; 1: 82.
27. Woestenburg AT, Mensch PP, Bosmans JL, et al. The morphometric analysis of renal vessels: The advantage of multi-sector area approach of cross-sections. Anal Quant Cytol Histol 2000; 22: 285.
28. Karpinski J, Lajoie G, Cattran D, et al. Outcome of kidney transplantation from high-risk donors is determined by both structure and function. Transplantation 1999; 67: 1162.
29. Kuypers D, Chapman J, O'Connell P, et al. Predictors of renal transplant histology at three months. Transplantation 1999; 67: 1222.
30. Oda A, Morozumi K, Uchida k. Histological factors of 1-hour biopsy influencing the delayed renal function and outcome in cadaveric renal allografts. Clin Transplant 1999; 13(suppl 1): 6.
31. Szanya J, Szakaly P, Magyarlaki T, et al. Predictive morphological findings in "zero-hour" biopsies of renal allografts. Acta Chir Hung 1997; 36: 346.
32. Wang H, Solez K, Kjellstrand C, et al. The importance of donor vascular pathology in determining renal allograft outcome. J Am Soc Nephrol 1998; 9: 702A.
33. Woestenburg A, Verbeelen D, Ysebaert D, et al. The impact of vasculopathy in the kidney allograft, at time of transplantation, on the subsequent function of the graft. J Am Soc Nephrol 2006; 17: 110A.
34. Taub H, Greenstein S, Lerner S, et al. Reassessment of the value of post-vascularization biopsy performed at renal transplantation: The effects of arteriosclerosis. J Urol 1994; 151: 575.
35. Bosmans JL, Woestenburg AT, Ysebaert DK, et al. Fibrous intimal thickening at implantation as a risk factor for the outcome of cadaveric renal allografts. Transplantation 2000; 69: 2388.
36. Bosmans JL, Woestenburg AT, Helbert MJ, et al. Impact of donor-related vascular alterations in implantation biopsies on morphologic and functional outcome of cadaveric renal allografts. Transplant Proc 2000; 32: 379.
37. Lu A, Desai D, Myers B, et al. Severe glomerulosclerosis is not associated with poor outcome after kidney transplantation. Am J Surg 2000; 180: 470.
38. Mota A, Arias M, Taskinen IE, et al. Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years. Am J Transplant 2004; 4: 953.
39. Randhawa P, Minervini M, Lombardero M, et al. Biopsy of marginal donor kidneys: Correlations of histologic findings with graft dysfunction. Transplantation 2000; 69: 1352.
40. Sugiyama S, Tsuyuki M, Okazaki Y, et al. Arteriosclerotic lesions of donor kidney and graft survival. Transplant Proc 1994; 26: 929.
41. Sund S, Reisaeter A, Fauchald P, et al. Living donor kidney transplants: A biopsy study 1 year after transplantation, compared with baseline changes and correlations to kidney function at 1 and 3 years. Nephrol Dial Transplant 1999; 14: 2445.
42. Woestenburg A, Verbeelen D, Ysebaert D, et al. The impact of vasculopathy in the kidney allograft, at the time of transplantation, on the subsequent function of the graft. Transpl Int 2007; 20(suppl 2): 48.
43. Randhawa P. Role of donor kidney biopsies in renal transplantation. Transplantation 2001; 71: 1361.
44. Seron D, Moreso F, Bover J, et al. Early protocol renal allograft biopsies and graft outcome. Kidney Int 1997; 51: 310.
45. Sund S, Reisaeter A, Scott H, et al. Morphological studies of baseline needle biopsies from living donor kidneys: Light microscopical, immunohistochemical and ultrastructural findings. APMIS 1998; 106: 1017.
46. Remuzzi G, Cravedi P, Perna A, et al. Long-term outcome of renal transplantation from older donors. N Engl J Med 2006; 354: 343.
47. Seron D, Fulladosa X, Moreso F. Risk factors associated with the deterioration of renal function after kidney transplantation. Kidney Int Suppl 2005; 99: 113.
48. Alperovich G, Maldonado R, Moreso F. Glomerular enlargement assessed by paired donor and early protocol renal allograft biopsies. Am J Transplant 2004; 4: 650.
49. Brenner BM, Cohen RA, Milford EL. In renal transplantation, one size may not fit all. J Am Soc Nephrol 1992; 3: 162.
50. Legendre C, Thervet E, Skhiri H, et al. Histologic features of chronic allograft nephropathy revealed by protocol biopsies in kidney transplants recipients. Transplantation 1998; 65: 1506.
51. Seron D, Moreso F, Ramon J, et al. Protocol renal allograft biopsies and the design of clinical trials aimed to prevent or treat chronic allograft nephropathy. Transplantation 2000; 69: 1849.
52. Seron D, Moreso F, Grinyo J. Prevention and management of late renal allograft dysfunction. J Nephrol 2001; 14: 71.
53. Wang H, Kjellstrand C, Cockfield S, et al. On the influence of sample size on the prognostic accuracy and reproducibility of renal transplant biopsy. Nephrol Dial Transplant 1998; 13: 165.
54. Yilmaz S, Tomlanovich S, Mathew T, et al. Protocol core needle biopsy and chronic allograft damage index as surrogate end point for long-term graft survival in multicenter studies. J Am Soc Nephrol 2003; 14: 773.